회원가입 | 연락처 | 사이트맵 | English

      회사소개 | 리포트 | 커스텀 리서치 | 고객지원


로그인

카테고리

유/무선통신

전기/전자

디지털기기/미디어/방송

Information Technology

에너지

생명공학

화학/신소재

자동차

환경

일반소비재

마케팅/광고

금융

건설

교통/운송

소비자조사

방위/항공/우주

식음료

중공업

교육

기계

무역

스포츠/레저

해운/조선

패션

정부/정책

공예/귀금속

컴퍼니 프로파일

기타산업

 
현재위치 : HOME > 리포트 > 생명공학 > 헬스케어
3D Printing In Healthcare Market: Role And Opportunities: By Technology (LBM, EBM, Stereolithography And Others); By Material (Metal, Cells And Others); By Application (Implants, Tissue Engineering And Others) & By Geography - Forecast (2015 - 2020)
발행사 IndustryARC

발행일 2015-08-27
분량 240 pages
서비스형태 Report
판매가격

인쇄하기

3D printing has begun to flourish in various application areas in healthcare such as dental, medical, implants, drug manufacturing and so on. The materials used for these purposes vary accordingly. While dental implants mostly use metals and ceramics to print dental crowns, the medical industry has its own array of bio-materials. As per IndustryARC analysis, the 3DP materials in healthcare market has revenue of $284.7 million as of 2014, and is estimated to grow at a CAGR of 19.1% over the next 6 years.

Reduction in prices of printers in healthcare 3D printing is estimated due to the growing demand and possible subsidies from governments as part of research grants as well. The commonly used materials for 3D printing of healthcare are plastics, metals, ceramics, donor cells, bone cement, biomaterials etc. Metal powders and biomaterials are expensive, wherein biomaterials are under research stage and are expected to be a prominent material for the 3D printing in healthcare industry. The global 3D printing in healthcare market recorded revenue of $487m in 2014 and is estimated to grow at a CAGR of 18.3% till 2020. The high growth rate in this market is due to increasing adaptation of 3D printing technologies into healthcare. This increasing adoption is due to wide spectrum of 3D printing applications in healthcare. The market is set to be driven by the increasing demand for patient-specific tailored products in orthopedics and maxillofacial surgery. Advances in tissue engineering for 3D bio-printing is gaining importance and the tissues generated by bio-printing will be available for transplant in the near future. However, high costs and regulatory barriers are likely to hinder the market growth.

North America is the leading consumer of 3D printing in healthcare industry, followed by Europe. Asia-Pacific’s (APAC’s) market is relatively small as compared to Americas region; however it is growing at a higher rate compared to Americas. With respect to the global market, the US itself holds 39.7% of the entire 3D printing in healthcare market share with existing major players like 3D Systems and Stratasys along with the new entrants and their investments to acquire the growing market. Europe is the second major market followed by APAC, together accounting for around 37% of the global 3D printing in healthcare market of 2014. Other factors affecting the growth of the market include technology innovation, efficiency and flexibility of printers and availability of good quality materials.

In this report, the market has been segmented by geography as America, Europe, Asia, and Rest of the World (RoW). Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the 3DP materials, printers, software and scanners market and future opportunities are provided in the report.

Key players covered in the market landscape analysis section are:
Digilab
EnvisionTEC
Invetech
MicroFab Technologies
nScrypt
Tevido BioDevices.


회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내

서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치
대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr
Copyright ⓒ 2008 LNH, Inc. All rights reserved.